NCT06907524

Brief Summary

The goal of this longitudinal study is to investigate the role of virtual health coaching on mitigation of cardiometabolic disease risk in an underserved, food insecure population. The main questions it aims to answer are:

  • Does longitudinal, individualized health coaching directed at lifestyle modification reduce patient 10-year risk of heart attack or stroke?
  • Does longitudinal, individualized health coaching directed at lifestyle modification reduce rates of hypertension, hyperlipidemia, and diabetes?
  • Does longitudinal, individualized health coaching directed at lifestyle modification improve accessibility to healthcare? Researchers will investigate the effects of regularly scheduled health coaching sessions on composite cardiometabolic risk profile as well as individual modifiable cardiovascular risk factors. Participants will:
  • Participate in in-person cardiovascular screening, occuring at the time of enrollment, months 3 and 6.
  • Engage in virtual health coaching sessions to talk about diet, exercise, weight loss, blood pressure and diabetes control, and accessibility to healthcare
  • Keep a log of their blood pressure

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
14mo left

Started Apr 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Apr 2025Jul 2027

First Submitted

Initial submission to the registry

March 26, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 2, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

April 2, 2025

Status Verified

March 1, 2025

Enrollment Period

2 years

First QC Date

March 26, 2025

Last Update Submit

March 26, 2025

Conditions

Keywords

Cardiovascular Disease PreventionCardiometabolic Disease ScreeningHypertensionHyperlipidemiaDiabetesLifestyle ModificationHealth CoachingCardiovascular Risk ScoreAtherosclerotic Cardiovascular Disease Risk ScoreCardiovascular Risk FactorCardiometabolic Disease

Outcome Measures

Primary Outcomes (1)

  • 10 - Year Atherosclerotic Cardiovascular Disease Risk Score

    Study data collected during in-person screening - occuring at the initial screening, 3 and 6 month rescreening - will be utilized to calculate the patient's 10-year Atherosclerotic Cardiovascular Disease (ASCVD) risk via the MD+ Calc ASCVD risk calculator from the American Heart Association (AHA)/American College of Cardiology (ACC).

    From enrollment to the end of study participation at 6 months.

Secondary Outcomes (9)

  • Depression - Patient Health Questionnaire - 2 (PHQ2)

    From enrollment to the end of study participation at 6 months.

  • Sleep Apnea - STOP-BANG

    From enrollment to the end of study participation at 6 months.

  • Point-of-care Hemoglobin A1c

    From enrollment to the end of study participation at 6 months.

  • Point-of-care Blood Lipid Level

    From enrollment to the end of study participation at 6 months.

  • Blood Pressure

    From enrollment to the end of study participation at 6 months.

  • +4 more secondary outcomes

Study Arms (1)

Intervention

EXPERIMENTAL

Patients will receive health coaching sessions, conducted by medical students and overseen by a licensed health coach, directed at individualized lifestyle modification relevant to the patient's cardiometabolic health profile. Patients will receive blood pressure cuffs and will be instructed as to how to measure and keep a log of their blood pressure to be reviewed during health coaching sessions. Sessions will occur biweekly for 1 month followed by the next 2 months. Sessions will last approximately 15 minutes in length. Objective data including blood pressure, point-of-care lipid panel and hemoglobin A1c, 10-year atherosclerotic cardiovascular disease (ASCVD) risk score, as well as surveys regarding depression, sleep apnea, physical activity, social determinants of health, and health literacy will be conducted at the time of study enrollment and at 3 and 6 months of study participation.

Behavioral: Longitudinal, Individualized Health Coaching

Interventions

During in-person events and screening - occurring at the initial screening, 3, and 6 months - patients will receive individualized health coaching by on-site physicians and nurse practitioners specializing in lifestyle medicine. Patients will receive virtual health coaching sessions, conducted by medical students and overseen by a licensed health coach, directed at individualized lifestyle modification relevant to the patient's cardiometabolic health profile. Interventions will include but not limited to: changes in diet, exercise, smoking, and drinking status. Patients will receive blood pressure cuffs and will be instructed as to how to measure and keep a log of their blood pressure to be reviewed during health coaching sessions. Sessions will occur biweekly for the first month and monthly for the following 2 months. Sessions will last approximately 15 minutes in length.

Intervention

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is a participant at a CHI sponsored, community screening event Patient provides informed consent and willingness to participate for the duration of the study English or Spanish speaking Age 40-75 years old At least 1 cardiometabolic risk factor at suboptimal level
  • Defined as one or more of the following at initial screening:
  • Blood Pressure (BP):
  • Systolic BP greater than 130mmHg and/or diastolic BP greater than 80mmHg. Obesity: body mass index (BMI) greater than 30 〖kg/m〗\^2
  • Dyslipidemia:
  • Total cholesterol greater than 200 mg/dL Triglycerides greater than 150 mg/dL Low density lipoprotein (LDL) greater than 130 mg/dL High density lipoprotein (HDL) less than 40 mg/dL in men or less than 50 mg/dL in women Hemoglobin A1c greater than or equal to 5.7% 10-year ASCVD score greater than 5% Access to a telehealth compatible device

You may not qualify if:

  • Adults unable to provide informed consent or unwilling to participate for study duration Speaks language other than English or Spanish Younger than 40 years old or older than 75 years old All cardiometabolic risk factors at optimal levels No telehealth compatible device Pregnant patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush University Medical Center

Chicago, Illinois, 60612, United States

Location

Related Publications (15)

  • Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin PH, Svetkey LP, Stedman SW, Young DR; Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003 Apr 23-30;289(16):2083-93. doi: 10.1001/jama.289.16.2083.

    PMID: 12709466BACKGROUND
  • Soltani D, Azizi B, Behnoush AH, Meysamie A, Aein A, Nayebirad S, Vasheghani-Farahani A, Akbari Sari A. Is lifestyle modification with individual face-to-face education and counseling more effective than usual care for controlling hypertension? A systematic review and meta-analysis of randomized controlled trials. Health Educ Res. 2023 Sep 20;38(5):490-512. doi: 10.1093/her/cyad028.

    PMID: 37450326BACKGROUND
  • Ma C, Zhou Y, Zhou W, Huang C. Evaluation of the effect of motivational interviewing counselling on hypertension care. Patient Educ Couns. 2014 May;95(2):231-7. doi: 10.1016/j.pec.2014.01.011. Epub 2014 Jan 30.

    PMID: 24530144BACKGROUND
  • Nakano M, Eguchi K, Sato T, Onoguchi A, Hoshide S, Kario K. Effect of Intensive Salt-Restriction Education on Clinic, Home, and Ambulatory Blood Pressure Levels in Treated Hypertensive Patients During a 3-Month Education Period. J Clin Hypertens (Greenwich). 2016 May;18(5):385-92. doi: 10.1111/jch.12770. Epub 2016 Jan 6.

    PMID: 26732187BACKGROUND
  • Seguin-Fowler RA, Strogatz D, Graham ML, Eldridge GD, Marshall GA, Folta SC, Pullyblank K, Nelson ME, Paul L. The Strong Hearts, Healthy Communities Program 2.0: An RCT Examining Effects on Simple 7. Am J Prev Med. 2020 Jul;59(1):32-40. doi: 10.1016/j.amepre.2020.01.027. Epub 2020 May 7.

    PMID: 32389532BACKGROUND
  • Koniak-Griffin D, Brecht ML, Takayanagi S, Villegas J, Melendrez M, Balcazar H. A community health worker-led lifestyle behavior intervention for Latina (Hispanic) women: feasibility and outcomes of a randomized controlled trial. Int J Nurs Stud. 2015 Jan;52(1):75-87. doi: 10.1016/j.ijnurstu.2014.09.005. Epub 2014 Sep 22.

    PMID: 25307195BACKGROUND
  • Kitzman H, Mamun A, Dodgen L, Slater D, King G, King A, Slater JL, DeHaven M. Better Me Within Randomized Trial: Faith-Based Diabetes Prevention Program for Weight Loss in African American Women. Am J Health Promot. 2021 Feb;35(2):202-213. doi: 10.1177/0890117120958545. Epub 2020 Sep 18.

    PMID: 32945175BACKGROUND
  • Buchanan Z, Hopkins SE, Ryman TK, Austin MA, Wiener HW, Tiwari HK, Klejka JA, Boyer BB, Fohner AE. Electronic health record reveals community-level cardiometabolic health benefits associated with 10 years of community-based participatory research. Public Health. 2024 Jul;232:38-44. doi: 10.1016/j.puhe.2024.04.010. Epub 2024 May 10.

    PMID: 38733959BACKGROUND
  • Liu Y, Eicher-Miller HA. Food Insecurity and Cardiovascular Disease Risk. Curr Atheroscler Rep. 2021 Mar 27;23(6):24. doi: 10.1007/s11883-021-00923-6.

    PMID: 33772668BACKGROUND
  • Kris-Etherton PM, Petersen KS, Velarde G, Barnard ND, Miller M, Ros E, O'Keefe JH, Williams K Sr, Horn LV, Na M, Shay C, Douglass P, Katz DL, Freeman AM. Barriers, Opportunities, and Challenges in Addressing Disparities in Diet-Related Cardiovascular Disease in the United States. J Am Heart Assoc. 2020 Apr 7;9(7):e014433. doi: 10.1161/JAHA.119.014433. Epub 2020 Mar 23.

    PMID: 32200727BACKGROUND
  • Powell-Wiley TM, Baumer Y, Baah FO, Baez AS, Farmer N, Mahlobo CT, Pita MA, Potharaju KA, Tamura K, Wallen GR. Social Determinants of Cardiovascular Disease. Circ Res. 2022 Mar 4;130(5):782-799. doi: 10.1161/CIRCRESAHA.121.319811. Epub 2022 Mar 3.

    PMID: 35239404BACKGROUND
  • Shahu A, Okunrintemi V, Tibuakuu M, Khan SU, Gulati M, Marvel F, Blumenthal RS, Michos ED. Income disparity and utilization of cardiovascular preventive care services among U.S. adults. Am J Prev Cardiol. 2021 Nov 6;8:100286. doi: 10.1016/j.ajpc.2021.100286. eCollection 2021 Dec.

    PMID: 34816144BACKGROUND
  • Kim YJ, Kim S, An J, Volgman AS, Nazir NT. Impact of the COVID-19 pandemic on cardiovascular disease mortality in a major metropolitan area. Am Heart J Plus. 2022 Jun;18:100173. doi: 10.1016/j.ahjo.2022.100173. Epub 2022 Jul 13.

    PMID: 35856067BACKGROUND
  • Woodruff RC, Tong X, Khan SS, Shah NS, Jackson SL, Loustalot F, Vaughan AS. Trends in Cardiovascular Disease Mortality Rates and Excess Deaths, 2010-2022. Am J Prev Med. 2024 Apr;66(4):582-589. doi: 10.1016/j.amepre.2023.11.009. Epub 2023 Nov 14.

    PMID: 37972797BACKGROUND
  • Ahmad FB, Anderson RN. The Leading Causes of Death in the US for 2020. JAMA. 2021 May 11;325(18):1829-1830. doi: 10.1001/jama.2021.5469. No abstract available.

    PMID: 33787821BACKGROUND

MeSH Terms

Conditions

HypertensionHyperlipidemiasDiabetes Mellitus

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesDyslipidemiasLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesGlucose Metabolism DisordersEndocrine System Diseases

Study Officials

  • Daniel Luger, MD

    Rush University Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: The described study is a longitudinal study directed at investigating the role of virtual health coaching on mitigation of cardiometabolic disease risk. Patients will be recruited from existing community screening events organized by the Cardiometabolic Health Initiative (CHI). CHI is a mobile screening clinic that provides comprehensive cardiometabolic health screenings to clients of food pantries on the west side of Chicago, Illinois. Eligible patients will be recruited and will receive individualized, virtual health coaching directed at lifestyle modification in order to improve cardiometabolic health.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chairman of Medicine, Rush Oak Park, Cardiovascular Prevention and Clinical Lipidology, Division of Cardiology

Study Record Dates

First Submitted

March 26, 2025

First Posted

April 2, 2025

Study Start

April 1, 2025

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

April 2, 2025

Record last verified: 2025-03

Locations